Paul Leurs

765 total citations
16 papers, 425 citations indexed

About

Paul Leurs is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Paul Leurs has authored 16 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Paul Leurs's work include Dialysis and Renal Disease Management (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Paul Leurs is often cited by papers focused on Dialysis and Renal Disease Management (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Paul Leurs collaborates with scholars based in Netherlands, Sweden and Japan. Paul Leurs's co-authors include Bengt Lindholm, Bruce H. R. Wolffenbuttel, Karly Hamulyák, René van Oerle, Peter Stenvinkel, Olof Heimbürger, Anna Machowska, Ronald P. Stolk, Naohito Isoyama and Björn Anderstam and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Paul Leurs

16 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Leurs Netherlands	11	181	109	98	94	68	16	425
Yume Nagaoka Japan	13	283 1.6×	65 0.6×	87 0.9×	248 2.6×	33 0.5×	39	569
Hiroshige Ohashi Japan	12	160 0.9×	85 0.8×	123 1.3×	98 1.0×	15 0.2×	34	389
Atsunori Kuwabara Japan	11	147 0.8×	96 0.9×	96 1.0×	57 0.6×	41 0.6×	19	506
Hisaki Shimada Japan	11	278 1.5×	85 0.8×	64 0.7×	54 0.6×	77 1.1×	19	471
Margien G. S. Boels Netherlands	8	233 1.3×	103 0.9×	94 1.0×	49 0.5×	40 0.6×	10	636
Shiwori Osada Japan	12	269 1.5×	117 1.1×	69 0.7×	81 0.9×	24 0.4×	26	518
F. Uccello Italy	11	245 1.4×	71 0.7×	64 0.7×	40 0.4×	17 0.3×	20	428
Kanji Shishido Japan	12	216 1.2×	101 0.9×	43 0.4×	57 0.6×	30 0.4×	26	360
Lena Norlund Sweden	10	134 0.7×	197 1.8×	95 1.0×	55 0.6×	198 2.9×	23	620
Günter Stein Germany	7	442 2.4×	141 1.3×	206 2.1×	71 0.8×	28 0.4×	8	704

Countries citing papers authored by Paul Leurs

Since Specialization

Citations

This map shows the geographic impact of Paul Leurs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Leurs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Leurs more than expected).

Fields of papers citing papers by Paul Leurs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Leurs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Leurs. The network helps show where Paul Leurs may publish in the future.

Co-authorship network of co-authors of Paul Leurs

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Leurs. A scholar is included among the top collaborators of Paul Leurs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Leurs. Paul Leurs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Knobbe, Tim J., Daan Kremer, Dorien M. Zelle, et al.. (2024). Effect of an exercise intervention or combined exercise and diet intervention on health-related quality of life-physical functioning after kidney transplantation: the Active Care after Transplantation (ACT) multicentre randomised controlled trial. The Lancet Healthy Longevity. 5(9). 100622–100622. 6 indexed citations

Machowska, Anna, Jia Sun, Abdul Rashid Qureshi, et al.. (2016). Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease. PLoS ONE. 11(10). e0163826–e0163826. 34 indexed citations

Isoyama, Naohito, Paul Leurs, Abdul Rashid Qureshi, et al.. (2014). Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients. Nephrology Dialysis Transplantation. 30(1). 84–91. 51 indexed citations

Leurs, Paul, Anna Machowska, & Bengt Lindholm. (2014). Timing of Dialysis Initiation: When to Start? Which Treatment?. Journal of Renal Nutrition. 25(2). 238–241. 18 indexed citations

Leurs, Paul, Bengt Lindholm, & Peter Stenvinkel. (2013). Effects of Hemodiafiltration on Uremic Inflammation. Blood Purification. 35(Suppl. 1). 11–17. 10 indexed citations

Leurs, Paul & Bengt Lindholm. (2013). The AGE–RAGE Pathway and Its Relation to Cardiovascular Disease in Patients with Chronic Kidney Disease. Archives of Medical Research. 44(8). 601–610. 23 indexed citations

Coussieu, Christiane, et al.. (2006). Leptin and old person's nutrition.. PubMed. 9(5). 327–9. 3 indexed citations

Smit, Watske, Natalie Schouten, Dirk G. Struijk, et al.. (2004). Analysis of the Prevalence and Causes of Ultrafiltration Failure during Long-Term Peritoneal Dialysis: A Cross-Sectional Study. Peritoneal Dialysis International. 24(6). 562–570. 86 indexed citations

Leurs, Paul, René van Oerle, Karly Hamulyák, & Bruce H. R. Wolffenbuttel. (2003). Tissue factor pathway inhibitor (TFPI) release after heparin stimulation is increased in Type 1 diabetic patients with albuminuria. Diabetic Medicine. 20(1). 16–22. 5 indexed citations

10.

Leurs, Paul, Ronald P. Stolk, Karly Hamulyák, et al.. (2002). Tissue Factor Pathway Inhibitor and Other Endothelium-Dependent Hemostatic Factors in Elderly Individuals With Normal or Impaired Glucose Tolerance and Type 2 Diabetes. Diabetes Care. 25(8). 1340–1345. 51 indexed citations

11.

Leurs, Paul, René van Oerle, Bruce H. R. Wolffenbuttel, & Karly Hamulyák. (1997). Increased Tissue Factor Pathway Inhibitor (TFPI) and Coagulation in Patients with Insulin-dependent Diabetes mellitus. Thrombosis and Haemostasis. 77(3). 472–476. 29 indexed citations

12.

Leurs, Paul, et al.. (1995). Tissue factor pathway inhibitor activity in patients with IDDM. Diabetes. 44(1). 80–84. 9 indexed citations

13.

Leurs, Paul, René van Oerle, Karly Hamulyák, & Bruce H. R. Wolffenbuttel. (1995). Tissue Factor Pathway Inhibitor Activity in Patients With IDDM. Diabetes. 44(1). 80–84. 20 indexed citations

14.

Wolffenbuttel, Bruce H. R., et al.. (1993). Lipoprotein(a) levels in relation to diabetic complications in patients with non‐insuIin‐dependent diabetes. European Journal of Clinical Investigation. 23(9). 580–584. 33 indexed citations

15.

Wolffenbuttel, Bruce H. R., et al.. (1993). Improved Blood Glucose Control by Insulin Therapy in Type 2 Diabetic Patients Has No Effect on Lipoprotein(a) Levels. Diabetic Medicine. 10(5). 427–430. 21 indexed citations

16.

Leurs, Paul, et al.. (1989). Acute renal failure after cardiovascular surgery. Current concepts in pathophysiology, prevention and treatment. European Heart Journal. 10(suppl H). 38–42. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact